XML 86 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Net loss attributable to Sterling common stockholders $ (73,929) $ (297) $ (35,900)
Plus: Noncontrolling owners’ interests in earnings of subsidiaries and joint ventures 3,903 18,009 1,196
Net income (loss) (70,026) 17,712 (34,704)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:      
Goodwill impairment     67,000
Depreciation and amortization 18,650 18,997 17,322
Gain on disposal of property and equipment (1,837) (3,184) (390)
Deferred tax expense (benefit) 5,150 (1,167) (18,651)
Interest expense accreted on noncontrolling interests   993 881
Stock-based compensation expense 928 694 503
Gain on sale of securities and other (85) (918) (3)
Tax impact from exercise of stock options and restricted stock 15 79 (58)
Changes in operating assets and liabilities:      
Contracts receivable (6,430) 4,060 1,933
Costs and estimated earnings in excess of billings on uncompleted contracts 8,908 (4,083) (5,921)
Receivables from and equity in construction joint ventures 4,887 (4,948) 687
Income tax receivable (6,011)    
Other current assets (6,717) (9,234) (538)
Accounts payables 13,794 7,730 (7,942)
Billings in excess of costs and estimated earnings on uncompleted contracts 12,658 335 (539)
Accrued compensation and other liabilities 4,554 (2,277) 1,408
Net cash provided by (used in) operating activities (21,562) 24,789 20,988
Cash flows from investing activities:      
Acquisition of noncontrolling interests   (23,144) (8,205)
Net assets of acquired companies, net of cash acquired     (3,911)
Additions to property and equipment (14,900) (37,359) (23,989)
Proceeds from sale of property and equipment 6,787 12,464 1,296
Purchases of short-term securities, available-for-sale (1,638) (30,154) (109,312)
Sales of short-term securities, available-for-sale 49,874 26,661 101,415
Net cash provided by (used in) investing activities 40,123 (51,532) (42,706)
Cash flows from financing activities:      
Cumulative daily drawdowns – Credit Facility 219,026 75,012 18,500
Cumulative daily repayments – Credit Facility (235,230) (51,000) (18,500)
Distributions to noncontrolling interest owners (3,565) (10,185) (7,809)
Purchases of treasury stock     (3,592)
Issuance of common stock pursuant to warrants and options exercised 26 68 156
Tax impact from exercise of stock options (15) (79) 58
Other (73) (302) (165)
Net cash provided by (used in) financing activities (19,831) 13,514 (11,352)
Net decrease in cash and cash equivalents (1,270) (13,229) (33,070)
Cash and cash equivalents at beginning of period 3,142 16,371 49,441
Cash and cash equivalents at end of period 1,872 3,142 16,371
Supplemental disclosures of cash flow information:      
Cash paid during the period for interest 595 88 299
Cash paid during the period for income taxes 170 2,990 1,444
Non-cash items:      
Reclassification of amounts payable to noncontrolling interest owner     1,054
Tax benefit related to the exercise of RHB’s liability     2,292
Net liabilities assumed in connection with acquisitions     1,961
Revaluation of noncontrolling interests (7,686) 3,992 (1,268)
Issuance of noncontrolling interest in RHB in exchange for net assets of acquired companies   9,767  
Goodwill adjustments   $ 410